Significado Clínico do Domínio da Peptidase M20 Contendo 1 em Pacientes com Aterosclerose Carotídea

Huang, Xincheng; He, Peiyuan; Wu, Linling.
Arq. bras. cardiol ; 119(3): 372-379, set. 2022. tab, graf
Artículo en Portugués | LILACS-Express | ID: biblio-1403345

Documentos relacionados

  1. Clinical Significance of Peptidase M20 Domain Containing 1 Ii Patients with Carotid Atherosclerosis.
  2. Effect of Leptin Levels of Type 2 Diabetes Mellitus and Diabetic Complications.
  3. Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease.
  4. Maternal metabolic syndrome in pregnancy and child development at age 5: exploring mediating mechanisms using cord blood markers.
  5. The effect of different high-intensity interval training protocols on cardiometabolic and inflammatory markers in sedentary young women: A randomized controlled trial.
  6. A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making.
  7. Triglyceride-Rich Lipoproteins: Their Role in Atherosclerosis.
  8. Effect of Reduction Mammoplasty on Insulin and Lipid Metabolism in the Postoperative Third month: Compensatory Hip Enlargement.
  9. Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
  10. [Age-related transformation of some lipid indicators under physical activity of varying intensity in male northerners.]